Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Oral Peppermint Supplementation on Cardiometabolic Parameters

NCT05071833 is registered in ClinicalTrials.gov with University of Central Lancashire as lead sponsor.

NCT NCT05071833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05071833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Oral Peppermint Supplementation on Cardiometabolic Parameters
Lead sponsor
University of Central Lancashire
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2021
Completion date
November 5, 2022
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiometabolic syndrome